|Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis|
D Vancampfort, CU Correll, B Galling, M Probst, M De Hert, PB Ward, ...
World Psychiatry 15 (2), 166-174, 2016
|Antipsychotic medication in schizophrenia: a review|
J Lally, JH MacCabe
British medical bulletin 114 (1), 169-179, 2015
|Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies|
J Lally, O Ajnakina, B Stubbs, M Cullinane, KC Murphy, F Gaughran, ...
The British Journal of Psychiatry 211 (6), 350-358, 2017
|Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses|
J Lally, O Ajnakina, M Di Forti, A Trotta, A Demjaha, A Kolliakou, ...
Psychological medicine 46 (15), 3231-3240, 2016
|Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial|
P Gardner-Sood, J Lally, S Smith, Z Atakan, K Ismail, KE Greenwood, ...
Psychological medicine 45 (12), 2619-2629, 2015
|Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: a systematic review and meta-analysis|
J Lally, J Tully, D Robertson, B Stubbs, F Gaughran, JH MacCabe
Schizophrenia research 171 (1-3), 215-224, 2016
|Vitamin D deficiency in first episode psychosis: a case–control study|
M Crews, J Lally, P Gardner-Sood, O Howes, S Bonaccorso, S Smith, ...
Schizophrenia research 150 (2-3), 533-537, 2013
|Stigma of mental illness and help-seeking intention in university students|
J Lally, A ˇ Conghaile, S Quigley, E Bainbridge, C McDonald
The Psychiatrist 37 (8), 253-260, 2013
|Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low-and middle-income countries|
B Stubbs, A Koyanagi, N Veronese, D Vancampfort, M Solmi, F Gaughran, ...
BMC medicine 14 (1), 1-12, 2016
|Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics|
J Lally, F Gaughran, P Timms, SR Curran
Pharmacogenomics and personalized medicine 9, 117, 2016
|Substance use, medication adherence and outcome one year following a first episode of psychosis|
M Colizzi, E Carra, S Fraietta, J Lally, D Quattrone, S Bonaccorso, ...
Schizophrenia research 170 (2-3), 311-317, 2016
|Clinical correlates of vitamin D deficiency in established psychosis|
J Lally, P Gardner-Sood, M Firdosi, C Iyegbe, B Stubbs, K Greenwood, ...
BMC psychiatry 16 (1), 1-9, 2016
|Prevalence and predictors of clozapine-associated constipation: a systematic review and meta-analysis|
A Shirazi, B Stubbs, L Gomez, S Moore, F Gaughran, RJ Flanagan, ...
International journal of molecular sciences 17 (6), 863, 2016
|Uncertainty and ambiguity and their association with psychological distress in medical students|
J Lally, P Cantillon
Academic Psychiatry 38 (3), 339-344, 2014
|Increases in triglyceride levels are associated with clinical response to clozapine treatment|
J Lally, A Gallagher, E Bainbridge, G Avalos, M Ahmed, C McDonald
Journal of Psychopharmacology 27 (4), 401-403, 2013
|Mental health services in the Philippines|
J Lally, J Tully, R Samaniego
BJPsych international 16 (3), 62-64, 2019
|Improving physical health and reducing substance use in psychosis–randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial|
F Gaughran, D Stahl, K Ismail, Z Atakan, J Lally, P Gardner-Sood, A Patel, ...
BMC psychiatry 13 (1), 1-10, 2013
|Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in establishedá…|
F Gaughran, D Stahl, K Ismail, K Greenwood, Z Atakan, P Gardner-Sood, ...
BMC psychiatry 17 (1), 1-14, 2017
|Hyperprolactinaemia in first episode psychosis-A longitudinal assessment|
J Lally, O Ajnakina, B Stubbs, HR Williams, M Colizzi, E Carra, S Fraietta, ...
Schizophrenia research 189, 117-125, 2017
|Clozapine-associated agranulocytosis treatment with granulocyte colony-stimulating factor/granulocyte-macrophage colony-stimulating factor: a systematic review|
J Lally, S Malik, E Whiskey, DM Taylor, FP Gaughran, A Krivoy, ...
Journal of clinical psychopharmacology 37 (4), 441-446, 2017